Patents by Inventor Marc ELLIOTT

Marc ELLIOTT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12329771
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: June 17, 2025
    Assignee: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20230255998
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: July 19, 2022
    Publication date: August 17, 2023
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Patent number: 11426423
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: August 30, 2022
    Assignee: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20200222446
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 16, 2020
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Patent number: 10632140
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: April 28, 2020
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Publication number: 20190247418
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Elliot Spira
  • Patent number: 10314855
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: June 11, 2019
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Spira
  • Publication number: 20180207196
    Abstract: The methods and assays described herein relate to detection, diagnosis, and treatment of lung cancer, e.g., by detecting the level of expression of certain miRNAs described herein and/or by therapeutically increasing the level of those miRNAs.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Applicant: Trustees of Boston University
    Inventors: Ana Brandusa Pavel, Joshua David Campbell, Marc Elliott Lenburg, Avrum Spira
  • Patent number: 9644329
    Abstract: A method of making hot mix asphalt using recycled asphalt in which tertiary air is mixed with products of combustion at an exit of a refractory-lined chamber to produce hot controlled temperature process air, the temperature of the tertiary air being increased while the temperature of the products of combustion is decreased to adjust a temperature of the hot controlled temperature process air. Particles of the recycled asphalt are heated by exposing the particles to the hot controlled temperature process air in the rotary counter-flow dryer and mixer and moisture is removed from the recycled asphalt with the hot controlled temperature process air.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: May 9, 2017
    Assignee: GENCOR INDUSTRIES, INC.
    Inventors: Joseph Mollick, Marc Elliott
  • Publication number: 20160201274
    Abstract: A method of making hot mix asphalt using recycled asphalt in which tertiary air is mixed with products of combustion at an exit of a refractory-lined chamber to produce hot controlled temperature process air, the temperature of the tertiary air being increased while the temperature of the products of combustion is decreased to adjust a temperature of the hot controlled temperature process air. Particles of the recycled asphalt are heated by exposing the particles to the hot controlled temperature process air in the rotary counter-flow dryer and mixer and moisture is removed from the recycled asphalt with the hot controlled temperature process air.
    Type: Application
    Filed: May 21, 2015
    Publication date: July 14, 2016
    Applicant: GENCOR INDUSTRIES, INC.
    Inventors: Joseph MOLLICK, Marc ELLIOTT
  • Publication number: 20120004205
    Abstract: The present invention concerns methods useful in diagnosing, identifying and monitoring the progression of eosinophilic esophagitis through measurements of gene products induced by IL-13.
    Type: Application
    Filed: December 1, 2009
    Publication date: January 5, 2012
    Applicant: Cincinnati Children's Hospital Medical Center
    Inventor: Marc Elliott Rothenberg